Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV)

Marion Mora, Giovanna Rincon, Michel Bourrelly, Gwenaëlle Maradan, Anaenza Freire Maresca, Florence Michard, Elisabeth Rouveix, Julie Pannetier, Diane Leriche, Tristan Alain, Yazdan Yazdanpanah, David Michels, Bruno Spire, Marion Mora, Giovanna Rincon, Michel Bourrelly, Gwenaëlle Maradan, Anaenza Freire Maresca, Florence Michard, Elisabeth Rouveix, Julie Pannetier, Diane Leriche, Tristan Alain, Yazdan Yazdanpanah, David Michels, Bruno Spire

Abstract

Introduction: Transgender identity is poorly accepted in France, and data on living conditions and the daily difficulties transgender people encounter are scarce. This lack of data reinforces their invisibility in social life, contributes to their stigmatisation and probably increases the burden of HIV infection, especially for HIV-positive transgender people (TRHIV). The main objective of the community-based research study ANRS Trans&HIV is to identify personal and social situations of vulnerability in TRHIV, the obstacles they encounter in terms of access to and retention in medical care, and their gender affirmation and HIV care needs.

Methods and analysis: ANRS Trans&HIV is a national, comprehensive, cross-sectional survey of all TRHIV currently being followed in HIV care units in France. TRHIV women are exclusively included in the quantitative component, and TRHIV men in the qualitative component. Data are collected by community-based interviewers and will be analysed to explore patient care pathways and living conditions in the TRHIV population with regard to gender affirmation and HIV. Data collection began in October 2020 and should be completed in December 2021. The statistical analyses techniques used will be adapted to each of the study's objectives and to the type of data collected (cross-sectional (questionnaires) and retrospective (biographical trajectory)). The study's results will provide a greater understanding of TRHIV health needs in order to suggest possible national recommendations for comprehensive HIV and gender affirmation medical care.

Ethics and dissemination: ANRS Trans&HIV was approved by Inserm's Ethical Evaluation Committee (no 20-694 on 12 May 2020) and is registered with the National Commission on Informatics and Liberty under number 2518030720. Potential participants are informed about the study through an information note provided by their attending HIV physician. All results published in peer-reviewed journals will be disseminated to the HIV transgender community, institutional stakeholders and healthcare providers.

Trial registration number: NCT04849767.

Keywords: HIV & AIDS; epidemiology; public health.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Chiam Z, Duffy S, Gil MG. Nigel Timothy Mpemba Pate. In: Trans legal mapping report 2019: recognition before the law. Genève: ILGA World, 2020.
    1. Nolan IT, Kuhner CJ, Dy GW. Demographic and temporal trends in transgender identities and gender confirming surgery. Transl Androl Urol 2019;8:184–90. 10.21037/tau.2019.04.09
    1. Scheim AI, Bauer GR. Sex and gender diversity among transgender persons in Ontario, Canada: results from a respondent-driven sampling survey. J Sex Res 2015;52:1–14. 10.1080/00224499.2014.893553
    1. Bauer G, Scheim A. Transgender people in Ontario. Canada: Statistics from the Trans PULSE Project to Inform Human Rights Policy, 2015.
    1. Pilling MD. Invisible identity in the workplace: intersectional madness and processes of disclosure at work. Disabil Stud Q 2012;33. 10.18061/dsq.v33i1.3424
    1. Bauer GR, Zong X, Scheim AI, et al. . Factors impacting transgender patients' discomfort with their family physicians: a Respondent-Driven sampling survey. PLoS One 2015;10:e0145046. 10.1371/journal.pone.0145046
    1. Bauer GR, Pyne J, Francino MC, Caron Francino M, et al. . Suicidality among trans people in Ontario: implications for social work and social justice. Serv Soc Que 2013;59:35–62. 10.7202/1017478ar
    1. Adams N, Hitomi M, Moody C. Varied reports of adult transgender suicidality: synthesizing and describing the peer-reviewed and gray literature. Transgend Health 2017;2:60–75. 10.1089/trgh.2016.0036
    1. Yüksel Şahika, Aslantaş Ertekin B, Öztürk M, et al. . A clinically neglected topic: risk of suicide in transgender individuals. Noro Psikiyatr Ars 2017;54:28–32. 10.5152/npa.2016.10075
    1. Narang P, Sarai SK, Aldrin S, et al. . Suicide among transgender and Gender-Nonconforming people. Prim Care Companion CNS Disord 2018;20. 10.4088/PCC.18nr02273. [Epub ahead of print: 21 Jun 2018].
    1. Longman Marcellin R, R. Bauer G, I. Scheim A. Intersecting impacts of transphobia and racism on HIV risk among trans persons of colour in Ontario, Canada. Ethnicity and Inequalities HSC 2013;6:97–107. 10.1108/EIHSC-09-2013-0017
    1. Becasen JS, Denard CL, Mullins MM, et al. . Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006-2017. Am J Public Health 2019;109:e1–8. 10.2105/AJPH.2018.304727
    1. Mayo-Wilson L, Benotsch E, Grigsby S. Combined effects of gender affirmation and economic hardship on vulnerability to HIV: a qualitative analysis among U.S. adult transgender women. BMC Public Health 2020;20. 10.1186/s12889-020-08902-3
    1. Sevelius JM, Carrico A, Johnson MO. Antiretroviral therapy adherence among transgender women living with HIV. J Assoc Nurses AIDS Care 2010;21:256–64. 10.1016/j.jana.2010.01.005
    1. Baral SD, Poteat T, Strömdahl S, et al. . Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis 2013;13:214–22. 10.1016/S1473-3099(12)70315-8
    1. Poteat T, Scheim A, Xavier J, et al. . Global epidemiology of HIV infection and related Syndemics affecting transgender people. J Acquir Immune Defic Syndr 2016;72 Suppl 3:S210–9. 10.1097/QAI.0000000000001087
    1. Mizuno Y, Frazier EL, Huang P, et al. . Characteristics of transgender women living with HIV receiving medical care in the United States. LGBT Health 2015;2:228–34. 10.1089/lgbt.2014.0099
    1. Dowshen N, Matone M, Luan X, et al. . Behavioral and health outcomes for HIV+ young transgender women (YTW) linked to and engaged in medical care. LGBT Health 2016;3:162–7. 10.1089/lgbt.2014.0062
    1. Radix A, Sevelius J, Deutsch MB. Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices. J Int AIDS Soc 2016;19:20810. 10.7448/IAS.19.3.20810
    1. Pommier J-D, Laouénan C, Michard F, et al. . Metabolic syndrome and endocrine status in HIV-infected transwomen. AIDS 2019;33:855–65. 10.1097/QAD.0000000000002152
    1. Lacombe-Duncan A, Bauer GR, Logie CH, et al. . The HIV care cascade among transgender women with HIV in Canada: a mixed-methods study. AIDS Patient Care STDS 2019;33:308–22. 10.1089/apc.2019.0013
    1. Clements-Nolle K, Marx R, Guzman R, et al. . Hiv prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health intervention. Am J Public Health 2001;91:915–21. 10.2105/ajph.91.6.915
    1. Reisner SL, White JM, Mayer KH, et al. . Sexual risk behaviors and psychosocial health concerns of female-to-male transgender men screening for STDs at an urban community health center. AIDS Care 2014;26:857–64. 10.1080/09540121.2013.855701
    1. Scheim AI, Bauer GR, Travers R. Hiv-Related sexual risk among transgender men who are gay, bisexual, or have sex with men. J Acquir Immune Defic Syndr 2017;74:e89–96. 10.1097/QAI.0000000000001222
    1. LOI n° 2016-1547 Du 18 novembre 2016 de modernisation de la justice Du XXIe siècle (1) 2016.
    1. Haute Autorité de Santé (HAS) . Rapport HAS 2009.pdf, 2009.
    1. Broussy S, Reigadas S, Vandenhende M. Caractéristiques sociodémographiques, identifications de genre, parcours de transition médicopsychologiques et VIH/sida dans la population trans. Premiers résultats d’une enquête menée en France en 2010, 2011. Available: [Accessed 16 Dec 2020].
    1. Giami A. Caractéristiques sociodémographiques, identifications de genre, parcours de transition médicopsychologiques et VIH/sida dans la population trans. In: Premiers résultats d’une enquête menée en France en. 12, 2010.
    1. Biello KB, Hughto JMW. Measuring intersectional stigma among racially and ethnically diverse transgender women: challenges and opportunities. Am J Public Health 2021;111:344–6. 10.2105/AJPH.2020.306141
    1. D’Almeida Wilson K, LERT F, Berdougo F. Kaygan d’Almeida Wilson.pdf, 2008.
    1. LERT F, Annequin M, Tron L. Situation socioéconomique des personnes vivant avec le VIH suivies l’hôpital en France métropolitaine en 2011. Premiers résultats de l’enquête ANRS-Vespa2, 2013. Available: [Accessed 7 Jun 2021].
    1. Marsicano E, Dray-Spira R, Lert F, et al. . Multiple discriminations experienced by people living with HIV in France: results from the ANRS-Vespa2 study. AIDS Care 2014;26 Suppl 1:S97–106. 10.1080/09540121.2014.907385
    1. Bail HL, Giametta C, Rassouw N. Que pensent les travailleur.se.s a Du sexe de la loi prostitution. 101, 2016.
    1. Lyons T, Krüsi A, Pierre L, et al. . Negotiating violence in the context of Transphobia and Criminalization: the experiences of trans sex workers in Vancouver, Canada. Qual Health Res 2017;27:182-190. 10.1177/1049732315613311
    1. Raho-Moussa M, Guiguet M, Michaud C, et al. . Respective roles of migration and social deprivation for virological non-suppression in HIV-infected adults on antiretroviral therapy in France. PLoS One 2019;14:e0213019. 10.1371/journal.pone.0213019
    1. Bouscarat F, Pommier J-D, Michard F, et al. . Infection à VIH, infections sexuellement transmises et complications dermatologiques chez les sujets transgenres consultant en centre hospitalo-universitaire. Résultats préliminaires chez 399 patients. Annales de Dermatologie et de Vénéréologie 2015;142:S485. 10.1016/j.annder.2015.10.122
    1. Bertin C, Abbas R, Andrieu V, et al. . Illicit massive silicone injections always induce chronic and definitive silicone blood diffusion with dermatologic complications. Medicine 2019;98:e14143. 10.1097/MD.0000000000014143
    1. Leung MW, Yen IH, Minkler M. Community based participatory research: a promising approach for increasing epidemiology's relevance in the 21st century. Int J Epidemiol 2004;33:499–506. 10.1093/ije/dyh010
    1. Katz-Wise SL, Pullen Sansfaçon A, Bogart LM, et al. . Lessons from a community-based participatory research study with transgender and gender nonconforming youth and their families. Action Res 2019;17:186–207. 10.1177/1476750318818875
    1. Beauchemin C, Hamel C, Lesné M. Discrimination: a question of visible minorities, 2010.
    1. Desgrées du Loû A, Parcours LF. Parcours de vie et santé des Africains immigrés en France. Paris: La Découverte, 2017.
    1. Le Cœur S, Im-Em W, Koetsawang S. Vulnérabilité et vie avec le VIH en Thaïlande : l’apport de l’approche biographique. Population 2005;60:551–68.
    1. JONES BL, NAGIN DS, ROEDER K. A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res 2001;29:374–93. 10.1177/0049124101029003005
    1. Nagin DS, Tremblay RE. Analyzing developmental trajectories of distinct but related behaviors: a group-based method. Psychol Methods 2001;6:18–34. 10.1037/1082-989X.6.1.18
    1. Nagin DS, Odgers CL. Group-Based trajectory modeling (nearly) two decades later. J Quant Criminol 2010;26:445–53. 10.1007/s10940-010-9113-7
    1. Coulaud P-J, Protopopescu C, Ndiaye K, et al. . Individual and healthcare supply-related barriers to treatment initiation in HIV-positive patients enrolled in the Cameroonian antiretroviral treatment access programme. Health Policy Plan 2021;36:137–48. 10.1093/heapol/czaa153
    1. Paillé P, Mucchielli A. Chapitre 11 - L’analyse thématique, 2012: 231–314.
    1. Association pour la recherche qualitative . Introduction l’analyse qualitative informatisée l’aide du logiciel QSR Nvivo 2.0. Rimouski: ARQ, 2005.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi